It is important to inform healthcare providers of all medications being taken, including over-the-counter products and supplements, as comprehensive medication review helps identify potential interactions or contributing factors to symptoms
This information will be valuable for your healthcare provider in determining whether symptoms represent panic attacks, medication side effects, or another medical condition requiring investigation
should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus Discontinue treatment in women at least 2 months before a planned pregnancy, owing to the long washout period for semaglutide Clinical Considerations Poorly controlled diabetes during pregnancy increases maternal risk for diabetic ketoacidosis, preeclampsia, spontaneous abortions, preterm delivery, stillbirth, and delivery complications Poorly controlled diabetes increases fetal risk for major birth defects, stillbirth, and macrosomia-related Interaction Coadministration with insulin secretagogues (eg, sulfonylureas) or insulin may increase the risk of hypoglycemia
Triple Receptor Agonist Mechanism and Comparative Clinical Data Retatrutide acts on three receptorsGLP-1, GIP, and glucagoncreating a distinct pharmacology compared to dual GLP-1/GIP agonists like tirzepatide
Contributes to a balanced intake of essential nutrients